Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Cue Biopharma Inc.

    NASDAQ: CUE · Real-Time Price · USD
    0.61
    0.02 (3.39%)
    At close: Jun 17, 2025, 10:15 AM

    Cue Biopharma Statistics

    Share Statistics

    Cue Biopharma has 75.35M shares outstanding. The number of shares has increased by 30.23% in one year.

    Shares Outstanding

    n/a
    		 75.35M

    Shares Change (YoY)

    n/a
    		 30.23%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 22.95%

    Shares Floating

    n/a
    		 74.78M

    Failed to Deliver (FTD) Shares

    n/a
    		 8,700

    FTD / Avg. Volume

    n/a
    		 5.31%

    Short Selling Information

    The latest short interest is 774.13K, so 1.03% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 774.13K

    Short % of Shares Out

    n/a
    		 1.03%

    Short % of Float

    n/a
    		 1.03%

    Short Ratio (days to cover)

    n/a
    		 3.83

    Valuation Ratios

    The PE ratio is -1.51 and the forward PE ratio is -1.4. Cue Biopharma's PEG ratio is 0.04.

    PE Ratio

    n/a
    		 -1.51

    Forward PE

    n/a
    		 -1.4

    PS Ratio

    n/a
    		 6.61

    Forward PS

    n/a
    		 0.1

    PB Ratio

    n/a
    		 3.51

    P/FCF Ratio

    n/a
    		 -1.69

    PEG Ratio

    n/a
    		 0.04
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Cue Biopharma.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 1.84, with a Debt / Equity ratio of 0.51.

    Current Ratio

    n/a
    		 1.84

    Quick Ratio

    n/a
    		 1.84

    Debt / Equity

    n/a
    		 0.51

    Debt / EBITDA

    n/a
    		 -0.24

    Debt / FCF

    n/a
    		 -0.24

    Interest Coverage

    n/a
    		 -52.14

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $226,512.2

    Profits Per Employee

    n/a
    		 $-992,048.78

    Employee Count

    n/a
    		 41

    Asset Turnover

    n/a
    		 0.29

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -55.97% in the last 52 weeks. The beta is 1.42, so Cue Biopharma's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.42

    52-Week Price Change

    n/a
    		 -55.97%

    50-Day Moving Average

    n/a
    		 0.71

    200-Day Moving Average

    n/a
    		 1.03

    Relative Strength Index (RSI)

    n/a
    		 34.12

    Average Volume (20 Days)

    n/a
    		 163,968

    Income Statement

    In the last 12 months, Cue Biopharma had revenue of 9.29M and earned -40.67M in profits. Earnings per share was -0.72.

    Revenue

    n/a
    		 9.29M

    Gross Profit

    n/a
    		 9.29M

    Operating Income

    n/a
    		 -41.5M

    Net Income

    n/a
    		 -40.67M

    EBITDA

    n/a
    		 -37.53M

    EBIT

    n/a
    		 -39.88M

    Earnings Per Share (EPS)

    n/a
    		 -0.72
    Full Income Statement

    Balance Sheet

    The company has 22.46M in cash and 8.88M in debt, giving a net cash position of 13.58M.

    Cash & Cash Equivalents

    n/a
    		 22.46M

    Total Debt

    n/a
    		 8.88M

    Net Cash

    n/a
    		 13.58M

    Retained Earnings

    n/a
    		 -341.86M

    Total Assets

    n/a
    		 22.25M

    Working Capital

    n/a
    		 433K
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -36.33M and capital expenditures -66K, giving a free cash flow of -36.4M.

    Operating Cash Flow

    n/a
    		 -36.33M

    Capital Expenditures

    n/a
    		 -66K

    Free Cash Flow

    n/a
    		 -36.4M

    FCF Per Share

    n/a
    		 -0.65
    Full Cash Flow Statement

    Margins

    Gross margin is 74.7%, with operating and profit margins of -446.86% and -437.97%.

    Gross Margin

    n/a
    		 74.7%

    Operating Margin

    n/a
    		 -446.86%

    Pretax Margin

    n/a
    		 -437.97%

    Profit Margin

    n/a
    		 -437.97%

    EBITDA Margin

    n/a
    		 -446.86%

    EBIT Margin

    n/a
    		 -446.86%

    FCF Margin

    n/a
    		 -391.89%

    Dividends & Yields

    CUE does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for CUE is $2.5, which is 323.7% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $2.5

    Price Target Difference

    n/a
    		 323.7%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 4
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 -25.98

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist